News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

On the left side of the graphic is a caucasian man wearing glasses and a suit. The photo shows him in portrait mode. The right side is blue and has a white logo and text.
News Release

Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.

Read More
A logo on white background
News Release

INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.

Read More
Doctor putting a protector on child's arm after vaccination
Media Coverage

America’s vaccine system faces more than a crisis of public confidence. It faces a potential operational breakdown. Changing vaccine recommendations without accounting for manufacturing capacity, supply chains, distribution networks and patient access risks turning uncertainty into shortages, delays and declining vaccination rates.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565

INFORMS in the News

What are you looking for?

Type of Content
Topic
Can the Digital Advertising Market Achieve Privacy without Regulation?

Can the Digital Advertising Market Achieve Privacy without Regulation?

News Release, March 8, 2021

CATONSVILLE, MD, March 8, 2021 – It’s a common assumption among marketers that if you can customize any form of marketing, particularly mobile advertising, you’ll get better results. With this in mind, mobile marketing relies significantly on user tracking data as a cornerstone advertising strategy.

Backlash Against Johnson & Johnson's COVID-19 Vaccine is Real and Risky - Here's How to Make Its Rollout A Success

Backlash Against Johnson & Johnson's COVID-19 Vaccine is Real and Risky - Here's How to Make Its Rollout A Success

The Conversation, March 5, 2021

More than 50 million Americans have received at least one dose of either the Pfizer or Moderna COVID-19 vaccine. So far, Americans have been largely brand-agnostic, but that’s about to change as a new vaccine rolls out. The Johnson & Johnson vaccine has been hailed as a game changer. It requires only a single dose rather than two doses spaced weeks apart, and it does not need freezer storage, making it a natural fit for hard-to-reach rural areas and underserved communities with limited access to health care and storage facilities. But while many people are excited about the prospects of only one shot, the new vaccine is also getting backlash. Part of that is coming from lack of clarity about the vaccines’ efficacy numbers, and part of it is more nuanced. 

Backlash Against Johnson & Johnson's COVID-19 Vaccine is Real and Risky - Here's How to Make Its Rollout A Success

Backlash Against Johnson & Johnson's COVID-19 Vaccine is Real and Risky - Here's How to Make Its Rollout A Success

Times Union, March 5, 2021

More than 50 million Americans have received at least one dose of either the Pfizer or Moderna COVID-19 vaccine. So far, Americans have been largely brand-agnostic, but that’s about to change as a new vaccine rolls out. The Johnson & Johnson vaccine has been hailed as a game changer. It requires only a single dose rather than two doses spaced weeks apart, and it does not need freezer storage, making it a natural fit for hard-to-reach rural areas and underserved communities with limited access to health care and storage facilities. But while many people are excited about the prospects of only one shot, the new vaccine is also getting backlash. Part of that is coming from lack of clarity about the vaccines’ efficacy numbers, and part of it is more nuanced.

Backlash Against Johnson & Johnson's COVID-19 Vaccine is Real and Risky - Here's How to Make Its Rollout A Success

Backlash Against Johnson & Johnson's COVID-19 Vaccine is Real and Risky - Here's How to Make Its Rollout A Success

My Journal Courier, March 5, 2021

More than 50 million Americans have received at least one dose of either the Pfizer or Moderna COVID-19 vaccine. So far, Americans have been largely brand-agnostic, but that’s about to change as a new vaccine rolls out. The Johnson & Johnson vaccine has been hailed as a game changer. It requires only a single dose rather than two doses spaced weeks apart, and it does not need freezer storage, making it a natural fit for hard-to-reach rural areas and underserved communities with limited access to health care and storage facilities. But while many people are excited about the prospects of only one shot, the new vaccine is also getting backlash. Part of that is coming from lack of clarity about the vaccines’ efficacy numbers, and part of it is more nuanced.

The Secret Behind North Dakota’s Speedy Vaccine Rollout

The Secret Behind North Dakota’s Speedy Vaccine Rollout

Wired, March 4, 2021

The pharmacy in Hankinson, North Dakota, a town of about 900 people at the state’s extreme southeastern tip, has been in operation since 1897. The town was a decade old by then and had quickly swelled with settlers enticed by ads for good farmland along the railroad. A pharmacy was one of those signs of a town’s arrival; a knowledgeable druggist was essential. This remained true through the years, even though it turned out that the region’s population had already peaked and was slowly dwindling, as it still is. The earliest owners of Hankinson Drug had kept a stock of jewelry as well as pharmaceuticals, and both traditions remain alive with the current proprietors. In recent years, their pharmacy has been the only one in the county outside Wahpeton, a bigger town 30 minutes away on the Minnesota border.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine